3H-spiperone labels sigma receptors, not dopamine D2 receptors, in rat and human lymphocytes

Teresa Coccini, Luigi Manzo, Lucio G. Costa

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

3H-Spiperone binds to dopamine D2 receptors in striatum and, under the assumption that it labels the same receptors in lymphocytes, this binding site has been suggested as a biological marker for schizophrenia. Recent studies, however, have raised questions about the existence of dopamine receptor changes in drug-free schizophrenic patients, as well as on the presence and/or dopaminergic nature of lymphocytic 3H-spiperone bindin the present study we have conducted an investigation of the binding of 3H-spiperone to rat and human lymphocytes. We found that 3H-spiperone binds in a specific, saturable and reversible manner to a site in lymphocytes; however, its dissociation constant Kd (9 nM) is about 40-fold higher than in striatum. An extensive investigation of the 3H-spiperone sites indicated that their pharmacological profile was not that of a dopamine D2 site, but rather that of sigma receptors, a novel class of non-dopaminergic, non-opioid receptors which bind with high affinity antipsychotic drugs. Sigma receptors were also identified in lymphocytes using the specific ligand 3H-DTG (1,3-di-o-tolyl-guanidine), whose binding characteristics were comparable to those of sigma receptors in rat brain. Receptor density and the pharmacological profile of 3H-spiperone and 3H-DTG were similar. Both compounds also labelled a higher number of sites in B cells than in T cells and a good correlation was found between the lymphocytic binding of both ligands in a group of 58 people. These findings indicate that sigma receptors are present in lymphocytes and suggest that 3H-spiperone binding in these cells occurs to sigma sites and not to dopamine D2 sites.

Original languageEnglish
Pages (from-to)93-105
Number of pages13
JournalImmunopharmacology
Volume22
Issue number2
DOIs
Publication statusPublished - 1991

Fingerprint

sigma Receptors
Spiperone
Dopamine D2 Receptors
Lymphocytes
Dopamine
Dissociative Disorders
Pharmacology
Ligands
Guanidine
Dopamine Receptors
Antipsychotic Agents
Schizophrenia
B-Lymphocytes
Biomarkers
Binding Sites
T-Lymphocytes
Brain

Keywords

  • H-Spiperone
  • Dopamine D receptors
  • Lymphocytes
  • Schizophrenia
  • Sigma receptors

ASJC Scopus subject areas

  • Pharmacology

Cite this

3H-spiperone labels sigma receptors, not dopamine D2 receptors, in rat and human lymphocytes. / Coccini, Teresa; Manzo, Luigi; Costa, Lucio G.

In: Immunopharmacology, Vol. 22, No. 2, 1991, p. 93-105.

Research output: Contribution to journalArticle

@article{6f55c2f109474f5281b0cf2730b9abca,
title = "3H-spiperone labels sigma receptors, not dopamine D2 receptors, in rat and human lymphocytes",
abstract = "3H-Spiperone binds to dopamine D2 receptors in striatum and, under the assumption that it labels the same receptors in lymphocytes, this binding site has been suggested as a biological marker for schizophrenia. Recent studies, however, have raised questions about the existence of dopamine receptor changes in drug-free schizophrenic patients, as well as on the presence and/or dopaminergic nature of lymphocytic 3H-spiperone bindin the present study we have conducted an investigation of the binding of 3H-spiperone to rat and human lymphocytes. We found that 3H-spiperone binds in a specific, saturable and reversible manner to a site in lymphocytes; however, its dissociation constant Kd (9 nM) is about 40-fold higher than in striatum. An extensive investigation of the 3H-spiperone sites indicated that their pharmacological profile was not that of a dopamine D2 site, but rather that of sigma receptors, a novel class of non-dopaminergic, non-opioid receptors which bind with high affinity antipsychotic drugs. Sigma receptors were also identified in lymphocytes using the specific ligand 3H-DTG (1,3-di-o-tolyl-guanidine), whose binding characteristics were comparable to those of sigma receptors in rat brain. Receptor density and the pharmacological profile of 3H-spiperone and 3H-DTG were similar. Both compounds also labelled a higher number of sites in B cells than in T cells and a good correlation was found between the lymphocytic binding of both ligands in a group of 58 people. These findings indicate that sigma receptors are present in lymphocytes and suggest that 3H-spiperone binding in these cells occurs to sigma sites and not to dopamine D2 sites.",
keywords = "H-Spiperone, Dopamine D receptors, Lymphocytes, Schizophrenia, Sigma receptors",
author = "Teresa Coccini and Luigi Manzo and Costa, {Lucio G.}",
year = "1991",
doi = "10.1016/0162-3109(91)90034-V",
language = "English",
volume = "22",
pages = "93--105",
journal = "Immunopharmacology",
issn = "0162-3109",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - 3H-spiperone labels sigma receptors, not dopamine D2 receptors, in rat and human lymphocytes

AU - Coccini, Teresa

AU - Manzo, Luigi

AU - Costa, Lucio G.

PY - 1991

Y1 - 1991

N2 - 3H-Spiperone binds to dopamine D2 receptors in striatum and, under the assumption that it labels the same receptors in lymphocytes, this binding site has been suggested as a biological marker for schizophrenia. Recent studies, however, have raised questions about the existence of dopamine receptor changes in drug-free schizophrenic patients, as well as on the presence and/or dopaminergic nature of lymphocytic 3H-spiperone bindin the present study we have conducted an investigation of the binding of 3H-spiperone to rat and human lymphocytes. We found that 3H-spiperone binds in a specific, saturable and reversible manner to a site in lymphocytes; however, its dissociation constant Kd (9 nM) is about 40-fold higher than in striatum. An extensive investigation of the 3H-spiperone sites indicated that their pharmacological profile was not that of a dopamine D2 site, but rather that of sigma receptors, a novel class of non-dopaminergic, non-opioid receptors which bind with high affinity antipsychotic drugs. Sigma receptors were also identified in lymphocytes using the specific ligand 3H-DTG (1,3-di-o-tolyl-guanidine), whose binding characteristics were comparable to those of sigma receptors in rat brain. Receptor density and the pharmacological profile of 3H-spiperone and 3H-DTG were similar. Both compounds also labelled a higher number of sites in B cells than in T cells and a good correlation was found between the lymphocytic binding of both ligands in a group of 58 people. These findings indicate that sigma receptors are present in lymphocytes and suggest that 3H-spiperone binding in these cells occurs to sigma sites and not to dopamine D2 sites.

AB - 3H-Spiperone binds to dopamine D2 receptors in striatum and, under the assumption that it labels the same receptors in lymphocytes, this binding site has been suggested as a biological marker for schizophrenia. Recent studies, however, have raised questions about the existence of dopamine receptor changes in drug-free schizophrenic patients, as well as on the presence and/or dopaminergic nature of lymphocytic 3H-spiperone bindin the present study we have conducted an investigation of the binding of 3H-spiperone to rat and human lymphocytes. We found that 3H-spiperone binds in a specific, saturable and reversible manner to a site in lymphocytes; however, its dissociation constant Kd (9 nM) is about 40-fold higher than in striatum. An extensive investigation of the 3H-spiperone sites indicated that their pharmacological profile was not that of a dopamine D2 site, but rather that of sigma receptors, a novel class of non-dopaminergic, non-opioid receptors which bind with high affinity antipsychotic drugs. Sigma receptors were also identified in lymphocytes using the specific ligand 3H-DTG (1,3-di-o-tolyl-guanidine), whose binding characteristics were comparable to those of sigma receptors in rat brain. Receptor density and the pharmacological profile of 3H-spiperone and 3H-DTG were similar. Both compounds also labelled a higher number of sites in B cells than in T cells and a good correlation was found between the lymphocytic binding of both ligands in a group of 58 people. These findings indicate that sigma receptors are present in lymphocytes and suggest that 3H-spiperone binding in these cells occurs to sigma sites and not to dopamine D2 sites.

KW - H-Spiperone

KW - Dopamine D receptors

KW - Lymphocytes

KW - Schizophrenia

KW - Sigma receptors

UR - http://www.scopus.com/inward/record.url?scp=0025918168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025918168&partnerID=8YFLogxK

U2 - 10.1016/0162-3109(91)90034-V

DO - 10.1016/0162-3109(91)90034-V

M3 - Article

VL - 22

SP - 93

EP - 105

JO - Immunopharmacology

JF - Immunopharmacology

SN - 0162-3109

IS - 2

ER -